Investor directory
Kurma Partners
Kurma Partners differentiates itself by actively building companies from disruptive scientific discoveries in healthcare.
What they invest in
Sectors
Geographies
Europe
The facts
- Typical cheque
- €100k – €30M
- Headquarters
- Paris, France
- Founded
- 2009
Portfolio
AM-PharmaPantera (Drug Discovery)Amolyt PharmaTargED BiopharmaceuticalsEmergence TherapeuticsVico TherapeuticsMedinCell (PAR: MEDCL)Merlyn MindVivet TherapeuticsEvlaBioMinoryxPharvaris (NAS: PHVS)ImCheck TherapeuticsCorteria PharmaceuticalsDynacureStep PharmaMemo TherapeuticsXeltisErmium TherapeuticsSunrise (Diagnostic Equipment)Shorla OncologyAdcytherixAlveus TherapeuticsAM Pharma
and 26 more
Does Kurma Partners fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Kurma Partners? Tell us what to correct and we will update it — or ask us to remove the entry.